CRO News
Reverb Therapeutics and Royalmount Join Forces for Lead Drug Development
Reverb Therapeutics has announced a collaboration with Montreal-based Royalmount Laboratories to support pre-IND enabling work on Reverb’s lead drug candidate, which is currently moving towards lead selection. The partnership will focus on critical bioanalytical and development tasks to prepare for